A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the efficacy, safety, and effect on hemoglobin levels, of once weekly
epoetin beta subcutaneous injections (30,000 International Units [IU]) in anemic patients
with solid tumors. The anticipated study duration is 4 months, and the target sample size is
40 individuals.